One Stop Shop for All Your Market Research Reports

Global (United States, European Union and China) Albumin (as Excipient) Market Research Report 2019-2025

Albumin is a water soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries Increase in usage of albumin as multifunctional excipient, shift toward usage of recombinant albumin, and grant of regulatory approvals are the key factors driving the market. However, high cost and expertise required to set up production plants and stringent regulatory criteria restrain the market. Emerging markets such as India, China, Brazil, and South Africa present significant opportunities in the albumin as an excipient market owing to growing contract research manufacturing. In 2019, the market size of Albumin (as Excipient) is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Albumin (as Excipient). This report studies the global market size of Albumin (as Excipient), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Albumin (as Excipient) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019. In global market, the following companies are covered: Albumedix A/S (Novozyme A/S) Albumin Therapeutics Biotest CSL Behring Grifols International HiMedia Laboratories InVitria Medxbio Octapharma RayBiotech SeraCare Life Sciences Merck Market Segment by Product Type Human Serum Albumin Recombinant Albumin Market Segment by Application Pharmaceutical & Biotechnology Industry Research Institutes Others Key Regions split in this report: breakdown data for each region. United States China European Union Rest of World (Japan, Korea, India and Southeast Asia) The study objectives are: To analyze and research the Albumin (as Excipient) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast. To present the key Albumin (as Excipient) manufacturers, presenting the sales, revenue, market share, and recent development for key players. To split the breakdown data by regions, type, companies and applications To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends, drivers, influence factors in global and regions To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market In this study, the years considered to estimate the market size of Albumin (as Excipient) are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Major Manufacturers Covered in This Report 1.3 Market Segment by Type 1.3.1 Global Albumin (as Excipient) Market Size Growth Rate by Type (2019-2025) 1.3.2 Human Serum Albumin 1.3.3 Recombinant Albumin 1.4 Market Segment by Application 1.4.1 Global Albumin (as Excipient) Market Share
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3280
Multi User US $4920
Corporate User US $6560
About this Report
Report ID 425241
Category
  • Pharmaceuticals and Healthcare
Published on 16-Sep
Number of Pages 117
Publisher Name QY Research
Editor Rating
★★★★★
★★★★★
(23)